STRONTIUM CHLORIDE Sr-89 (BIO NUCLEONICS INC)


Welcome to the PulseAid listing for the STRONTIUM CHLORIDE Sr-89 drug offered from BIO NUCLEONICS INC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: BIO NUCLEONICS INC
NON-PROPRIETARY NAME: STRONTIUM CHLORIDE SR-89
SUBSTANCE NAME: STRONTIUM CHLORIDE SR-89
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2003-01-06
END MARKETING DATE: 0000-00-00


STRONTIUM CHLORIDE Sr-89 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSTRONTIUM CHLORIDE Sr-89 from BIO NUCLEONICS INC
LABELER NAME: BIO NUCLEONICS INC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mCi/mL)
START MARKETING DATE: 2003-01-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65909-089_50e0768b-260a-0b95-8685-1095713008f7
PRODUCT NDC: 65909-089
APPLICATION NUMBER: ANDA075941

Other STRONTIUM CHLORIDE SR-89 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BIO NUCLEONICS INCSTRONTIUM CHLORIDE Sr-89
Medi-Physics Inc.Metastron